There are several myopia control management options.
At Valley Optometry we offer several options including the newly approved MiSight contact lenses and atropine drop therapy. These treatments have been shown to slow the progression of myopia.
MiSight Daily Contact Lenses
MiSight 1 Day contact lens is currently the only FDA approved soft contact lens indicated to slow the progression of myopia (nearsightedness) in children, aged 8-12 at the initiation of treatment (1). The contact lens is a daily disposable lens that needs to be worn ≥ 10 hours per day and ≥ 6 days per week. In the clinical trial, most children enjoyed wearing their lenses 11 to 14 hours per day. The latest data analysis found abnormal axial length growth slowed by an average of approximately 50% with all tested ages (8-17) (2).
Atropine Drop Therapy
Low dose atropine has been studied and found to slow the progression of myopia (nearsightedness) in children, aged 4 to 12 at the initiation of treatment (3). The drops are utilized nightly, 7 days per week to achieve maximum effectivity.
(1)Chamberlain P, Bradley A, Arumugam B, et al. Long-term Effect of Dual-focus Contact Lenses on Myopia Progression in Children: A 6-year Multicenter Clinical Trial. Optom Vis Sci. 2022;99(3):204-212.
(2) Baskar Arumugam, Arthur Bradley, David Hammond, Paul Chamberlain; Modelling Age Effects of Myopia Progression for the MiSight 1 day Clinical Trial. Invest. Ophthalmol. Vis. Sci. 2021;62(8):2333.
(3) Yam, Jason C et al. “Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout: Phase 3 Report.” Ophthalmology vol. 129,3 (2022): 308-321. doi:10.1016/j.ophtha.2021.10.002